IDEXX Laboratories, Inc. (LON:0J8P)

London flag London · Delayed Price · Currency is GBP · Price in USD
454.32
+5.43 (1.21%)
At close: Feb 20, 2025
-17.28%
Market Cap 29.33B
Revenue (ttm) 3.11B
Net Income (ttm) 709.20M
Shares Out n/a
EPS (ttm) 8.52
PE Ratio 41.35
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 214
Average Volume 311
Open 451.62
Previous Close 448.89
Day's Range 451.55 - 456.54
52-Week Range 373.77 - 583.30
Beta 1.37
RSI 56.74
Earnings Date Feb 3, 2025

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnos... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1983
Employees 11,000
Stock Exchange London Stock Exchange
Ticker Symbol 0J8P
Full Company Profile

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Financial numbers in USD Financial Statements

News

IDEXX Laboratories Inc (IDXX) Announces Participation in Upcoming Investor Conferences

IDEXX Laboratories Inc (IDXX) Announces Participation in Upcoming Investor Conferences

9 days ago - GuruFocus

IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: Thursday, February 27, 9:05 am –...

9 days ago - Business Wire

Options Movement At IDEXX Laboratories: Michael G Erickson Exercises Worth $597K

A substantial insider activity was disclosed on February 12, as Erickson, Executive Vice President at IDEXX Laboratories (NASDAQ: IDXX), reported the exercise of a large sell of company stock options...

9 days ago - Benzinga

Insider Decision: George Fennell Exercises Options At IDEXX Laboratories For $4.28M

In a new SEC filing on February 11, it was revealed that Fennell, Executive Vice President at IDEXX Laboratories (NASDAQ: IDXX), executed a significant exercise of company stock options. What Happene...

10 days ago - Benzinga

M. Anne Szostak Implements A Sell Strategy: Offloads $1.40M In IDEXX Laboratories Stock

A substantial insider sell was reported on February 10, by M. Anne Szostak , Director at IDEXX Laboratories (NASDAQ: IDXX), based on the recent SEC filing. What Happened: Szostak's recent move involv...

11 days ago - Benzinga

IDEXX Laboratories And Its Real Value

12 days ago - Seeking Alpha

Idexx Laboratories (IDXX) Stock Surge: Key Drivers

Idexx Laboratories (IDXX) Stock Surge: Key Drivers

16 days ago - GuruFocus

IDEXX Laboratories: I See Pet Healthcare As An Interesting Market For The Future

IDEXX Laboratories is poised for growth in the pet healthcare market. Check out why I see a 50% upside in IDXX stock by FY27.

16 days ago - Seeking Alpha

IDEXX Laboratories Inc (IDXX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

IDEXX Laboratories Inc (IDXX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations Propel Performance

19 days ago - GuruFocus

Q4 2024 IDEXX Laboratories Inc Earnings Call Transcript

Q4 2024 IDEXX Laboratories Inc Earnings Call Transcript

19 days ago - GuruFocus

Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today's Top S&P 500 Performers.

Idexx Laboratories, AbbVie, and Molina Healthcare trade higher on a down day for Wall Street.

19 days ago - Barrons

IDEXX Laboratories, Inc. (IDXX) Q4 2024 Earnings Call Transcript

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2024 Earnings Conference Call February 3, 2025 8:30 AM ETCompany ParticipantsBrian McKeon - Chief Financial...

19 days ago - Seeking Alpha

IDEXX Laboratories Stock Jumps on Testing Products Demand, Higher Prices

IDEXX Laboratories exceeded fourth-quarter profit and revenue estimates on sales of its animal testing products and price increases.

19 days ago - Investopedia

IDEXX stock jumps 12% as Q4 report, outlook top Street estimates

IDEXX (IDXX) stock jumped 12% in early trading Monday after the pet healthcare company issued a Q4 earnings report and 2025 forecast that topped Street expectations. Read more here.

19 days ago - Seeking Alpha

Idexx Laboratories Barks Up A Beat, And Shares Jump To A Four-Month High

Idexx Laboratories handily beat Wall Street's fourth-quarter expectations Monday, and Idexx stock gapped up to a four-month high.

19 days ago - Investor's Business Daily

Why Is Pet Health Company IDEXX Laboratories Stock Trading Higher On Monday?

IDEXX Laboratories Inc (NASDAQ: IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the consensus of $2.40 . The pet healthcare company reported sales of $954.3 millio...

19 days ago - Benzinga

Why Is Pet Health Company IDEXX Laboratories Stock Trading Higher On Monday?

IDEXX Laboratories Inc IDXX reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the consensus of $2.40.

19 days ago - Benzinga

Earnings Summary: Highlights of IDEXX’s Q4 2024 report

Medical device company IDEXX Laboratories, Inc. (NASDAQ: IDXX) on Monday reported higher revenues and net income for the fourth quarter of 2024. Fourth-quarter revenues increased 6% annually to $954.3...

19 days ago - AlphaStreet

Idexx: Q4 EPS, Revenue Beat Forecast

Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.

19 days ago - The Motley Fool

Animal diagnostics maker IDEXX beats quarterly estimates despite low vet visits

IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits to t...

20 days ago - Reuters

IDEXX Laboratories Exceeds Q4 Estimates with $2.62 EPS and $954 Million Revenue

IDEXX Laboratories Exceeds Q4 Estimates with $2.62 EPS and $954 Million Revenue

20 days ago - GuruFocus

IDEXX Laboratories GAAP EPS of $2.62 beats by $0.22, revenue of $954M beats by $17.32M

IDEXX Laboratories beats Q4 expectations with earnings and revenue growth, providing a positive outlook for 2025.

20 days ago - Seeking Alpha

IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results. “IDEXX had a solid finis...

20 days ago - Business Wire

Earnings Scheduled For February 3, 2025

Companies Reporting Before The Bell • Tyson Foods (NYSE: TSN) is projected to report quarterly earnings at $0.88 per share on revenue of $13.46 billion. • Saia (NASDAQ: SAIA) is projected to report ...

20 days ago - Benzinga